Boulay, J., Mild, G., Lowy, A., Reuter, J., Lagrange, M., Terracciano, L., . . . Rochlitz, C. (2002). SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Nature Publishing Group.
Chicago Style CitationBoulay, J-L, G. Mild, A. Lowy, J. Reuter, M. Lagrange, L. Terracciano, U. Laffer, R. Herrmann, i C. Rochlitz. SMAD4 Is a Predictive Marker for 5-fluorouracil-based Chemotherapy in Patients With Colorectal Cancer. Nature Publishing Group, 2002.
Cita MLABoulay, J-L, et al. SMAD4 Is a Predictive Marker for 5-fluorouracil-based Chemotherapy in Patients With Colorectal Cancer. Nature Publishing Group, 2002.
Atenció: Aquestes cites poden no estar 100% correctes.